Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Synaptic Loss as the Key Driver of Dementia Dihexa's theoretical mechanism focuses on synaptic preservation rather than amyloid reduction
(PubMed) US Food and Drug Administration
Sigma-tau Industrie Farmaceutiche Riunite S.p.A
However, when researchers treated these damaged immune cells with ROS-lowering agents like NAC in the laboratory setting, the intervention successfully reduced the intracellular oxidative damage and reversed the functional cellular defects
US$ 25.89
US$ 28.92
US$ 26.31
US$ 20.29
US$ 25.45
